Carna Biosciences, Inc. Logo

Carna Biosciences, Inc.

Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.

4572 | T

Overview

Corporate Details

ISIN(s):
JP3220550002
LEI:
Country:
Japan
Address:
神戸市中央区港島南町一丁目5番5号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Carna Biosciences, Inc. is a clinical-stage biopharmaceutical company founded in 2003, specializing in the discovery and development of innovative kinase inhibitor drugs. The company focuses on creating small molecule therapies to address unmet medical needs in oncology, autoimmune diseases, and neurodegenerative disorders. Carna Biosciences operates a dual business model: advancing its proprietary drug pipeline for out-licensing and providing comprehensive drug discovery support services. These services include the manufacturing of kinase proteins, as well as offering profiling, screening, and assay development to support pharmaceutical and biotechnology research globally. The company leverages its deep expertise in kinase biology to develop novel therapeutic candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 07:45
Registration Form
訂正有価証券届出書(組込方式)
Japanese 347.4 KB
2025-09-12 08:46
Registration Form
訂正有価証券届出書(組込方式)
Japanese 325.6 KB
2025-08-07 02:46
Registration Form
訂正有価証券届出書(組込方式)
Japanese 243.9 KB
2025-08-07 02:45
Registration Form
訂正有価証券届出書(組込方式)
Japanese 244.0 KB
2025-08-07 02:43
Interim Report
確認書
Japanese 8.8 KB
2025-08-07 02:42
Interim Report
半期報告書-第23期(2025/01/01-2025/12/31)
Japanese 358.3 KB
2025-07-11 08:47
Registration Form
有価証券届出書(組込方式)
Japanese 393.6 KB
2025-07-11 08:46
Registration Form
有価証券届出書(組込方式)
Japanese 393.6 KB
2025-07-11 08:45
Registration Form
有価証券届出書(組込方式)
Japanese 392.8 KB
2025-03-28 02:41
Regulatory News Service
臨時報告書
Japanese 28.5 KB
2025-03-26 02:11
Governance Information
内部統制報告書-第22期(2024/01/01-2024/12/31)
Japanese 24.5 KB
2025-03-26 02:10
Registration Form
確認書
Japanese 8.7 KB
2025-03-26 02:08
Annual Report
有価証券報告書-第22期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2024-09-25 08:39
Share Issue/Capital Change
臨時報告書
Japanese 122.5 KB
2024-08-08 02:51
Report Publication Announcement
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all Carna Biosciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Carna Biosciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Carna Biosciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

TechnoPro Holdings, Inc. Logo
Technology staffing and services group providing engineers and solutions for R&D and development.
Japan
6028
TechTarget, Inc. Logo
Provides purchase intent-driven marketing and sales services for B2B tech vendors.
United States of America
TTGT
Tenaya Therapeutics, Inc. Logo
Developing gene therapy, cellular regeneration & precision medicine for heart disease.
United States of America
TNYA
Terns Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing small-molecule drugs for oncology & metabolic diseases.
United States of America
TERN
A holding company active in property rentals and marine seismic & defense R&D.
Virgin Islands (British)
THAL
Holding company for real estate development, building management, and community-integrated hotels.
Japan
3271
The Lifestyle Group Logo
Developed luxury/well-being ventures & provided multimedia systems for franchise network growth.
Italy
TLSG
Theranexus Logo
A biopharma developing drugs for rare neurological diseases by targeting non-neuronal cells.
France
ALTHX
THE WHY HOW DO COMPANY, Inc. Logo
A corporate regeneration platform for business turnarounds, M&A, and succession solutions.
Japan
3823
Tiziana Life Sciences Ltd Logo
Biotech firm developing immunotherapies for neurodegenerative diseases like MS and Alzheimer's.
United States of America
TLSA

Talk to a Data Expert

Have a question? We'll get back to you promptly.